Industry News | tctmd.com

News Industry News

St. Jude Medical Launches Global Clinical Trial to Evaluate a New Therapy Option for Patients at an Increased Risk of Stroke Due to Atrial Fibrillation

September 01, 2016

News Industry News

Isis Pharmaceuticals Announces Initiation of an Investigator-Sponsored Phase 2 Study of ISIS-TTR Rx in Patients with TTR Cardiomyopathy Amyloidosis

December 16, 2015

News Industry News

Roxwood Medical Proceeds with Full US Launch of Its MicroCross™ Catheter after 500+ Patients Are Successfully Treated during Limited Release

December 15, 2015

News Industry News

Study Demonstrates i-cor® Synchronized Cardiac Assist Preserves Left Ventricular (LV) Function Compared to Continuous-Flow ECLS in Cardiogenic Shock

December 15, 2015

News Industry News

Boston Scientific Receives FDA Approval And CE Mark For AngioJet™ ZelanteDVT™ Thrombectomy Catheter

November 30, 2015

News Industry News

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)

November 29, 2015

News Industry News

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

November 19, 2015

News Industry News

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

October 26, 2015

News Industry News

Mitralign Announces Enrollment of First U.S. Subject in Percutaneous Tricuspid Repair Study

December 02, 2015

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) Reports First Patient Treated for Mitral Regurgitation (“MR”)

November 22, 2015

Subscribe to Industry News

Advertisement

St. Jude Medical Launches Global Clinical Trial to Evaluate a New Therapy Option for Patients at an Increased Risk of Stroke Due to Atrial Fibrillation

Isis Pharmaceuticals Announces Initiation of an Investigator-Sponsored Phase 2 Study of ISIS-TTR Rx in Patients with TTR Cardiomyopathy Amyloidosis

Roxwood Medical Proceeds with Full US Launch of Its MicroCross™ Catheter after 500+ Patients Are Successfully Treated during Limited Release

Study Demonstrates i-cor® Synchronized Cardiac Assist Preserves Left Ventricular (LV) Function Compared to Continuous-Flow ECLS in Cardiogenic Shock

Boston Scientific Receives FDA Approval And CE Mark For AngioJet™ ZelanteDVT™ Thrombectomy Catheter

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

Mitralign Announces Enrollment of First U.S. Subject in Percutaneous Tricuspid Repair Study

NaviGate Cardiac Structures Inc. (“NCSI”) Reports First Patient Treated for Mitral Regurgitation (“MR”)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content